Ustekinumab Approvals Arrive In UK And Canada For Formycon And Fresenius
Otulfi Partnered Biosimilar To Stelara Is Approved By MHRA And Health Canada
Partners Fresenius and Formycon have racked up another pair of approvals for their Otulfi ustekinumab biosimilar rival to Stelara, this time in the UK and Canada.
